Ellie Collins
Pharmaceutical companies help humans stay healthy, so we wondered what they are doing for planetary health, by focusing on the greenhouse gas emissions produced by pharmaceutical companies that are adding to climate change.
Read More
We are proud to announce our top 20 position as a great place to work for well-being. At Oxford PharmaGenesis, we have a caring and nurturing culture, and we look out for each other, so this accolade is the work of many. We would like to take this opportunity to especially thank the efforts of […]
Read More
To find information about medicine, people search databases that contain articles related to the topic. Many literature databases tag articles to help to categorize the type of publication. This helps users to access relevant information more easily. For example, if someone is looking for a report about a clinical trial or a review to get […]
Read More
DPhil student, Dr Amy Booth (University of Oxford) and Oxford PharmaGenesis CEO, Dr Chris Winchester, have co-authored a new study published in the International Journal of Environmental Research and Public Health this month, revealing the climate change targets of the 20 leading global pharmaceutical companies – and how they are reporting on and reducing their […]
Read More
Oxford PharmaGenesis has secured Great Place to Work® accreditation for a third consecutive year in the UK and a seventh consecutive year in the US. This was awarded based on average scores across a number of statements and 90% of colleagues who responded to the survey agreed that “Taking everything into account, I would say this is a great place to work”.
Read More
The ISMPP EU conference took place in London on 24–25 January. Themed around ‘Fueling Creativity’, sessions explored how to access creativity, improve collaboration and arrive at unexpected solutions.
Read More
Join our healthy debate at the 2023 European Meeting of ISMPP and explore new frontiers with Oxford PharmaGenesis.
Read MoreTo ensure that patients receive optimal healthcare, clinicians rely on the best available evidence, which is often synthesized in a systematic literature review (SLR) or meta-analysis. The problem is that research never stands still, so new findings are constantly being published. This means that unless an SLR is continually updated, new findings may remain buried […]
Read More
Space medicine, digital health and the patient voice were just some of the topics explored at the inaugural 2022 Australian Pharmaceutical Professionals Association (APPA) and Medical Affairs Professional Society (MAPS) joint Medical Affairs summit for the Australia and New Zealand (ANZ) region, held on 17 and 18 November in Sydney, Australia.
Read More
As part of our commitment to promoting equality, diversity and inclusivity (EDI) in the workplace and across the work that we do, Oxford PharmaGenesis is proud to sponsor the latest CISCRP educational media campaign which promotes greater patient diversity in clinical trials.
Read More